Log in to save to my catalogue

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gast...

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gast...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2071564450

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

About this item

Full title

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2018-09, Vol.24 (9), p.1449-1458

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifying determinants of response, we performed molecular characterization of tissues and circulating tumor DNA (ctDNA) from 61 patients with mGC who were treated with pembrolizum...

Alternative Titles

Full title

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2071564450

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2071564450

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-018-0101-z

How to access this item